{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T07:08:41Z","timestamp":1791443321702,"version":"4.3.3"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003341","name":"Cambridge Overseas Trust","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003341","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Medical Research Council"},{"name":"James Baird Fund"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.nbd.2014.02.004","type":"journal-article","created":{"date-parts":[[2014,2,18]],"date-time":"2014-02-18T21:15:59Z","timestamp":1392758159000},"page":"19-27","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Dopaminergic manipulations and its effects on neurogenesis and motor function in a transgenic mouse model of Huntington's disease"],"prefix":"10.1016","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9414-8214","authenticated-orcid":false,"given":"M.L.","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Begeti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.H.","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.Y.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.C.","family":"O'Keeffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.D.","family":"Clelland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Tyers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.H.","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.B.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.A.","family":"Barker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Pt 12","key":"10.1016\/j.nbd.2014.02.004_bb0005","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1093\/brain\/122.12.2353","article-title":"Huntington's disease progression. PET and clinical observations","volume":"122","author":"Andrews","year":"1999","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2014.02.004_bb0010","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1365-2990.1982.tb00266.x","article-title":"Effects of haloperidol on cell proliferation in the early postnatal brain","volume":"8","author":"Backhouse","year":"1982","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.nbd.2014.02.004_bb0015","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/1467-9450.00238","article-title":"Dopamine and cognitive functioning: brain imaging findings in Huntington's disease and normal aging","volume":"42","author":"B\u00e4ckman","year":"2001","journal-title":"Scand. J. Psychol."},{"key":"10.1016\/j.nbd.2014.02.004_bb0020","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1750-1326-3-17","article-title":"Optimisation of region-specific reference gene selection and relative gene expression analysis methods for pre-clinical trials of Huntington's disease","volume":"3","author":"Benn","year":"2008","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.nbd.2014.02.004_bb0025","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1097\/NEN.0b013e3181ea167f","article-title":"Environmental enrichment reduces neuronal intranuclear inclusion load but has no effect on messenger RNA expression in a mouse model of Huntington disease","volume":"69","author":"Benn","year":"2010","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2014.02.004_bb0030","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00213-008-1068-0","article-title":"The effects of modafinil on mood and cognition in Huntington's disease","volume":"199","author":"Blackwell","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.nbd.2014.02.004_bb0035","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1471-4159.2006.04241.x","article-title":"Dopamine and adult neurogenesis","volume":"100","author":"Borta","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2014.02.004_bb0040","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.brainresbull.2011.01.010","article-title":"Longitudinal analysis of the behavioural phenotype in R6\/1 (C57BL\/6J) Huntington's disease transgenic mice","volume":"88","author":"Brooks","year":"2012","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.nbd.2014.02.004_bb0045","doi-asserted-by":"crossref","first-page":"6480","DOI":"10.1073\/pnas.95.11.6480","article-title":"Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human Huntington disease gene","volume":"95","author":"Cha","year":"1998","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.nbd.2014.02.004_bb0050","doi-asserted-by":"crossref","first-page":"12218","DOI":"10.1073\/pnas.0502698102","article-title":"Unraveling a role for dopamine in Huntington's disease: the dual role of reactive oxygen species and D2 receptor stimulation","volume":"102","author":"Charvin","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2014.02.004_bb0055","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1126\/science.1173215","article-title":"A functional role for adult hippocampal neurogenesis in spatial pattern separation","volume":"325","author":"Clelland","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.nbd.2014.02.004_bb0060","doi-asserted-by":"crossref","first-page":"7487","DOI":"10.1073\/pnas.1204542109","article-title":"Dysregulation of dopamine receptor D2 as a sensitive measure for Huntington disease pathology in model mice","volume":"109","author":"Crook","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2014.02.004_bb0065","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1093\/hmg\/ddl224","article-title":"Aberrant cortical synaptic plasticity and dopaminergic dysfunction in a mouse model of Huntington's disease","volume":"15","author":"Cummings","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2014.02.004_bb0070","doi-asserted-by":"crossref","first-page":"11035","DOI":"10.1073\/pnas.1831768100","article-title":"Sustained elevation of extracellular dopamine causes motor dysfunction and selective degeneration of striatal GABAergic neurons","volume":"100","author":"Cyr","year":"2003","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.nbd.2014.02.004_bb0075","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000322540","article-title":"Impaired long-term potentiation in the prefrontal cortex of Huntington's disease mouse models: rescue by D1 dopamine receptor activation","volume":"8","author":"Dallerac","year":"2011","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.nbd.2014.02.004_bb0080","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s007020050061","article-title":"Adult treatment with haloperidol increases dentate granule cell proliferation in the gerbil hippocampus","volume":"105","author":"Dawirs","year":"1998","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.nbd.2014.02.004_bb0085","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.nbd.2008.01.015","article-title":"Sertraline slows disease progression and increases neurogenesis in N171-82Q mouse model of Huntington's disease","volume":"30","author":"Duan","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2014.02.004_bb0090","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1471-4159.1992.tb09283.x","article-title":"Increased cerebrospinal fluid dopamine and 3,4-dihydroxyphenylacetic acid levels in Huntington's disease: evidence for an overactive dopaminergic brain transmission","volume":"58","author":"Garrett","year":"1992","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2014.02.004_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0278-5846(96)00157-1","article-title":"The dopaminergic mesencephalic projections to the hippocampal formation in the rat","volume":"21","author":"Gasbarri","year":"1997","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.nbd.2014.02.004_bb0100","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.nbd.2005.05.006","article-title":"Reduced hippocampal neurogenesis in R6\/2 transgenic Huntington's disease mice","volume":"20","author":"Gil","year":"2005","journal-title":"Neurobiol. Dis."},{"issue":"Pt 3","key":"10.1016\/j.nbd.2014.02.004_bb0105","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/brain\/120.3.503","article-title":"PET study of the pre- and post-synaptic dopaminergic markers for the neurodegenerative process in Huntington's disease","volume":"120","author":"Ginovart","year":"1997","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2014.02.004_bb0110","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0306-4522(03)00595-5","article-title":"Delayed onset of Huntington's disease in mice in an enriched environment correlates with delayed loss of cannabinoid CB1 receptors","volume":"123","author":"Glass","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2014.02.004_bb0120","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1440-1681.2007.04610.x","article-title":"Regulators of adult neurogenesis in the healthy and diseased brain","volume":"34","author":"Grote","year":"2007","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.nbd.2014.02.004_bb0115","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1111\/j.1460-9568.2005.04365.x","article-title":"Cognitive disorders and neurogenesis deficits in Huntington's disease mice are rescued by fluoxetine","volume":"22","author":"Grote","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2014.02.004_bb9000","first-page":"1543","article-title":"Dissection of hippocampal dentate gyrus from adult mouse","volume":"17","author":"Hagihara","year":"2009","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.nbd.2014.02.004_bb0125","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1046\/j.1471-4159.2002.00804.x","article-title":"The role of dopamine in motor symptoms in the R6\/2 transgenic mouse model of Huntington's disease","volume":"81","author":"Hickey","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2014.02.004_bb0130","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/nn1265","article-title":"Dopamine depletion impairs precursor cell proliferation in Parkinson disease","volume":"7","author":"Hoglinger","year":"2004","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2014.02.004_bb0135","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1212\/01.wnl.0000198586.85250.13","article-title":"Tetrabenazine as antichorea therapy in Huntington disease: a randomized controlled trial","volume":"66","author":"Huntington Study Group","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2014.02.004_bb0140","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1097\/NEN.0b013e3181ee005d","article-title":"Hyperdopaminergic status in experimental Huntington disease","volume":"69","author":"Jahanshahi","year":"2010","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2014.02.004_bb0145","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0166-2236(00)01568-X","article-title":"Neuronal cell death in Huntington's disease: a potential role for dopamine","volume":"23","author":"Jakel","year":"2000","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.nbd.2014.02.004_bb0150","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.2042-7158.1968.tb09743.x","article-title":"The quantitative measurement of motor inco-ordination in naive mice using an accelerating rotarod","volume":"20","author":"Jones","year":"1968","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.nbd.2014.02.004_bb9005","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.2967\/jnumed.107.040550","article-title":"Performance measurement of the microPET Focus 120 scanner","volume":"48","author":"Kim","year":"2007","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.nbd.2014.02.004_bb0155","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.nbd.2013.09.015","article-title":"Resolving pathobiological mechanisms relating to Huntington disease: gait, balance, and involuntary movements in mice with targeted ablation of striatal D1 dopamine receptor cells","volume":"62","author":"Kim","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2014.02.004_bb0160","doi-asserted-by":"crossref","first-page":"5815","DOI":"10.1523\/JNEUROSCI.1120-05.2005","article-title":"Dopamine specifically inhibits forebrain neural stem cell proliferation, suggesting a novel effect of antipsychotic drugs","volume":"25","author":"Kippin","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2014.02.004_bb0165","doi-asserted-by":"crossref","first-page":"14075","DOI":"10.1523\/JNEUROSCI.0692-13.2013","article-title":"Dopamine D2 receptors regulate collateral inhibition between striatal medium spiny neurons","volume":"33","author":"Lalchandani","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2014.02.004_bb0170","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1097\/00001756-200404090-00014","article-title":"Decreased hippocampal cell proliferation in R6\/1 Huntington's mice","volume":"15","author":"Lazic","year":"2004","journal-title":"NeuroReport"},{"key":"10.1016\/j.nbd.2014.02.004_bb0175","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1111\/j.1460-9568.2006.04715.x","article-title":"Neurogenesis in the R6\/1 transgenic mouse model of Huntington's disease: effects of environmental enrichment","volume":"23","author":"Lazic","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2014.02.004_bb0180","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0079-6123(07)63004-0","article-title":"Extrinsic afferent systems to the dentate gyrus","volume":"163","author":"Leranth","year":"2007","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.nbd.2014.02.004_bb9010","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1097\/00004647-199609000-00008","article-title":"Distribution volume ratios without blood sampling from graphical analysis of PET data","volume":"16","author":"Logan","year":"1996","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.nbd.2014.02.004_bb0185","doi-asserted-by":"crossref","first-page":"9104","DOI":"10.1523\/JNEUROSCI.20-24-09104.2000","article-title":"Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus","volume":"20","author":"Malberg","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2014.02.004_bb0190","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2014.02.004_bb0195","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1517\/14728210902918299","article-title":"Emerging drug therapies in Huntington's disease","volume":"14","author":"Mason","year":"2009","journal-title":"Expert Opin. Emerg. Drugs"},{"key":"10.1016\/j.nbd.2014.02.004_bb0200","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1046\/j.1471-4159.1998.70062406.x","article-title":"Toxicity of dopamine to striatal neurons in vitro and potentiation of cell death by a mitochondrial inhibitor","volume":"70","author":"McLaughlin","year":"1998","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2014.02.004_bb0205","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.neuron.2011.05.001","article-title":"Adult neurogenesis in the mammalian brain: significant answers and significant questions","volume":"70","author":"Ming","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2014.02.004_bb0210","doi-asserted-by":"crossref","first-page":"4113","DOI":"10.1523\/JNEUROSCI.4913-10.2011","article-title":"Dopaminergic modulation of cortical inputs during maturation of adult-born dentate granule cells","volume":"31","author":"Mu","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2014.02.004_bb0215","doi-asserted-by":"crossref","first-page":"8754","DOI":"10.1073\/pnas.0803955106","article-title":"Dopamine-induced proliferation of adult neural precursor cells in the mammalian subventricular zone is mediated through EGF","volume":"106","author":"O'Keeffe","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.nbd.2014.02.004_bb0220","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neulet.2011.01.036","article-title":"Impaired dopamine release and uptake in R6\/1 Huntington's disease model mice","volume":"492","author":"Ortiz","year":"2011","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2014.02.004_bb0225","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/hmg\/ddn385","article-title":"Altered serotonin receptor expression is associated with depression-related behavior in the R6\/1 transgenic mouse model of Huntington's disease","volume":"18","author":"Pang","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2014.02.004_bb0230","doi-asserted-by":"crossref","first-page":"10090","DOI":"10.1523\/JNEUROSCI.3237-08.2008","article-title":"Dopaminergic and glutamatergic signaling crosstalk in Huntington's disease neurodegeneration: the role of p25\/cyclin-dependent kinase 5","volume":"28","author":"Paoletti","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2014.02.004_bb0235","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1093\/brain\/awg119","article-title":"Progressive striatal and cortical dopamine receptor dysfunction in Huntington\u2019s disease: a PET study","volume":"126","author":"Pavese","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2014.02.004_bb0240","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.nbd.2009.10.015","article-title":"Cortical dopamine dysfunction in symptomatic and premanifest Huntington's disease gene carriers","volume":"37","author":"Pavese","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2014.02.004_bb9015","series-title":"The mouse brain in stereotaxic coordinates","author":"Paxinos","year":"2001"},{"key":"10.1016\/j.nbd.2014.02.004_bb0245","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1093\/hmg\/10.12.1243","article-title":"Expanded CAG repeats in exon 1 of the Huntington's disease gene stimulate dopamine-mediated striatal neuron autophagy and degeneration","volume":"10","author":"Peters\u00e9n","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2014.02.004_bb0250","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1006\/nbdi.2002.0534","article-title":"Evidence for dysfunction of the nigrostriatal pathway in the R6\/1 line of transgenic Huntington's disease mice","volume":"11","author":"Petersen","year":"2002","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2014.02.004_bb0255","doi-asserted-by":"crossref","first-page":"11564","DOI":"10.1523\/JNEUROSCI.3796-05.2005","article-title":"Abnormalities of neurogenesis in the R6\/2 mouse model of Huntington's disease are attributable to the in vivo microenvironment","volume":"25","author":"Phillips","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2014.02.004_bb0260","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1002\/mds.22188","article-title":"A Europe-wide assessment of current medication choices in Huntington's disease","volume":"23","author":"Priller","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2014.02.004_bb0265","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s10048-013-0364-y","article-title":"Candidate gluta matergic and dopaminergic pathway gene variants do not influence Huntington's disease motor onset","volume":"14","author":"Ramos","year":"2013","journal-title":"Neurogenetics"},{"key":"10.1016\/j.nbd.2014.02.004_bb0270","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1111\/j.1476-5381.2011.01567.x","article-title":"Treatment of depressive-like behaviour in Huntington's disease mice by chronic sertraline and exercise","volume":"165","author":"Renoir","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.nbd.2014.02.004_bb0275","doi-asserted-by":"crossref","first-page":"10116","DOI":"10.1523\/JNEUROSCI.18-23-10116.1998","article-title":"Dopamine modulates the susceptibility of striatal neurons to 3-nitropropionic acid in the rat model of Huntington's disease","volume":"18","author":"Reynolds","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2014.02.004_bb0280","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","article-title":"Huntington's disease: from molecular pathogenesis to clinical treatment","volume":"10","author":"Ross","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2014.02.004_bb0285","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1126\/science.1172545","article-title":"Dopamine controls persistence of long-term memory storage","volume":"325","author":"Rossato","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.nbd.2014.02.004_bb0290","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/nature09817","article-title":"Increasing adult hippocampal neurogenesis is sufficient to improve pattern separation","volume":"472","author":"Sahay","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2014.02.004_bb0295","doi-asserted-by":"crossref","first-page":"12908","DOI":"10.1523\/JNEUROSCI.4318-07.2007","article-title":"Neuroprotective effects of synaptic modulation in Huntington's disease R6\/2 mice","volume":"27","author":"Stack","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2014.02.004_bb0300","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/0306-4522(95)00587-0","article-title":"Methamphetamines pretreatment and the vulnerability of the striatum to methamphetamine neurotoxicity","volume":"72","author":"Stephans","year":"1996","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2014.02.004_bb0305","doi-asserted-by":"crossref","first-page":"7899","DOI":"10.1523\/JNEUROSCI.1396-07.2007","article-title":"Dopaminergic signaling and striatal neurodegeneration in Huntington's disease","volume":"27","author":"Tang","year":"2007","journal-title":"J. Neurosci."},{"issue":"Pt 3","key":"10.1016\/j.nbd.2014.02.004_bb0310","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1093\/brain\/118.3.689","article-title":"Striatal D1 and D2 receptor binding in patients with Huntington's disease and other choreas. A PET study","volume":"118","author":"Turjanski","year":"1995","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2014.02.004_bb0315","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1468-1331.2008.02390.x","article-title":"Changes in striatal dopamine D2 receptor binding in pre-clinical Huntington's disease","volume":"16","author":"Van Oostrom","year":"2009","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.nbd.2014.02.004_bb0320","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00441-011-1196-4","article-title":"Immunohistological markers for proliferative events, gliogenesis, and neurogenesis within the adult hippocampus","volume":"345","author":"Von Bohlen und Halbach","year":"2011","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.nbd.2014.02.004_bb0325","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/jnr.10281","article-title":"Atypical neuroleptics stimulate neurogenesis in adult rat brain","volume":"69","author":"Wakade","year":"2002","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.nbd.2014.02.004_bb0330","doi-asserted-by":"crossref","first-page":"e18153","DOI":"10.1371\/journal.pone.0018153","article-title":"The latent stem cell population is retained in the hippocampus of transgenic Huntington's disease mice but not wild-type mice","volume":"6","author":"Walker","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.nbd.2014.02.004_bb0335","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/nrn1406","article-title":"Dopamine, learning and motivation","volume":"5","author":"Wise","year":"2004","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2014.02.004_bb0340","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1523\/JNEUROSCI.3574-07.2008","article-title":"Ciliary neurotrophic factor mediates dopamine D2 receptor-induced CNS neurogenesis in adult mice","volume":"28","author":"Yang","year":"2008","journal-title":"J. Neurosci."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996114000394?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996114000394?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T15:13:54Z","timestamp":1565190834000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996114000394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":72,"alternative-id":["S0969996114000394"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2014.02.004","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dopaminergic manipulations and its effects on neurogenesis and motor function in a transgenic mouse model of Huntington's disease","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2014.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}